Home / Agriculture / Direct-fed Microbials Market
Direct-fed Microbials Market Size, Share & Industry Analysis, By Type (Lactic Acid Bacteria, Bacillus, and Others), By Form (Dry and Liquid), By End-Use (Pork/Swine, Ruminants, Poultry, and Others), Regional Forecast, 2024-2032
Report Format: PDF | Published Date: Ongoing | Report ID: FBI107217 | Status : UpcomingDirect-fed microbials consist of viable microorganisms such as bacteria or yeast that aid in improving the overall growth and performance of livestock. These microbials contribute to the improvement of digestive-related disorders and impart numerous nutritional and medicinal advantages to the animals.
The recent years recorded an escalated demand for direct-fed microbials. This is due to the mounting demand for the proteinaceous products and substitution of the role of antibiotic promoters with the direct-fed microbials in animal feed. Moreover, the rising awareness about animal welfare, the prevalence of chronic diseases, and the massive demand for organic or natural feed is expected to augment direct-fed microbials market share. Several factors, such as soaring concerns for feed safety, higher rate of industrialization, and growing resources for R&D about innovative product launches, will further open lucrative opportunities for market growth.
It has been 20 years since the launch of these products. However, their use has not been recognized due to the poor awareness regarding its advantages among the population. The exponential growth of the market is majorly due to the positive effects of the product on milk production and feed efficiency, which paves the way for market growth. Furthermore, the ban on antibiotic usage and emerging awareness about animal nutrition amongst the consumers and rearers helps to foster the market growth.
Impact of COVID-19 on Direct-fed Microbials Market
The COVID-19 pandemic severely threatened manufacturing operations in numerous countries worldwide. The nationwide lockdown imposed a halt on the procurement and supply chain of industries. Such instances affected the momentum of the global market. Factors such as fluctuations in the cost of raw material and disruptions in the supply chain directly hampered the direct-fed microbials market growth during the pandemic period. Strict regulations imposed by various governments have also been responsible for terminating the overall growth of the market.
Key Insights
The report will cover the following key insights:
- Overview of parent/related market
- Key growth strategies by industry players
- Regulatory analysis
- Impact of COVID-19 on direct-fed microbials market
Analysis by Livestock
Based on the livestock, the market is segmented into poultry, ruminants, swine, and others (aquatic animals, equine, and pets). The poultry segment is expected to witness a considerable surge as the consumption of poultry has been increasing over the past decades. This is mainly due to the beneficial impact on human health owing to high nutrient value. The rise in poultry production is further expected to boost the demand for direct-fed microbials.
Regional Analysis
North America held the largest market revenue share in the global market. Numerous factors, such as easy accessibility and growing livestock production, have been responsible for the growing popularity of direct-fed microbials in the North American region.
The Asia Pacific market is expected to exhibit substantial growth in the upcoming years. This is due to the rising awareness regarding product usage in animal feed.
Key Players
The report includes the profile of key players such as Archer Daniels Midland Company (U.S.), Kemin Industries (U.S.), Novus International Inc, (U.S.), Bio-vet (U.S.), Biomin Holding GmbH (Austria), Lallemand Inc. (Canada), Koninklijke DSM N.V (Netherlands), and E.I du Pont de Nemours and Company (U.S.).
Segmentation
By Type | By Form | By End-User | By Geography |
|
|
|
|
Key Industrial Developments
- June 2020 - Chr. Hansen Holdings A/S entered into an agreement with UAS Laboratories LLC, a Wisconsin-based company specialized in clinically documented probiotics. Through this agreement, Chr. Hansen fully acquired UAS Labs.
- Global
- 2023
- 2019-2022